NCT04413357

Brief Summary

This will be a randomized crossover design with nutrition supplement interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started May 2020

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2020

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

May 29, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2020

Completed
Last Updated

October 21, 2024

Status Verified

October 1, 2024

Enrollment Period

24 days

First QC Date

May 29, 2020

Last Update Submit

October 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area under the blood glucose curve

    Area under the blood glucose curve (AUC 0-240 minutes)

    Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Secondary Outcomes (2)

  • Area under the insulin curves

    Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

  • Insulinogenic index

    Baseline, 10, 20, 30, 60, 90, 120, 150, 180, 210 and 240 minutes

Study Arms (3)

Balanced Nutritional Drink

ACTIVE COMPARATOR

The study interventions contain protein, carbohydrate and fat and are intended for use as Supplemental Nutrition.

Other: Balanced Nutritional Drink

Balanced Nutritional Drink - DMA

ACTIVE COMPARATOR

The study interventions contain protein, carbohydrate and fat and are intended for use as retail Supplemental Nutrition for people living with diabetes.

Other: Diabetes Specific, Balanced Nutritional Drink (DMA)

Balanced Nutritional Drink - DMB

ACTIVE COMPARATOR

The study interventions contain protein, carbohydrate and fat and are intended for use as Supplemental Nutrition for people living with diabetes.

Other: Diabetes Specific, Balanced Nutritional Drink DMB

Interventions

Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat intended for use as Supplemental Nutrition.

Balanced Nutritional Drink

Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat, designed for people living with diabetes and intended for use as Supplemental Nutrition available in retail setting.

Balanced Nutritional Drink - DMA

Drink 1 cup of liquid nutrition product that contains protein, carbohydrate and fat, designed for people living with diabetes and intended for use as Supplemental Nutrition.

Balanced Nutritional Drink - DMB

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20-75 years
  • Type 2 diabetes controlled with diet or diet and metformin (Glucophage)
  • Hemoglobin A1C less than 9.0%
  • Fasting blood glucose less than 180 mg
  • Hematocrit levels within normal limits
  • Having obtained his/her informed consent

You may not qualify if:

  • Abnormal thyroid function
  • Creatinine \>2.0 mg/dl
  • Potassium \<3.5 mEq/l
  • Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting
  • Currently unstable diabetes or under treatment for cancer, heart disease, renal disease
  • Unable to give informed consent or follow instructions
  • Current insulin therapy or insulin therapy within the past month
  • Patient who are pregnant
  • Allergies to milk, soy or any component of the test product
  • Patient who in the investigators assessment cannot be expected to comply with treatment
  • Currently participating or having participated in another clinical trial
  • Patients with anemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orange County Research Center

Tustin, California, 92780, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

HLA-DM antigens

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Krysmaru Araujo Torres, MD

    Nestle Health Science

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Site pharmacy will not be blinded to product assignment, study staff and participants will be blinded to product assignment. Product will be provided in unlabeled cups.
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: This will be a randomized crossover design. The subjects will be randomized to one of three interventions on three separate study days, one week apart.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 29, 2020

First Posted

June 2, 2020

Study Start

May 18, 2020

Primary Completion

June 11, 2020

Study Completion

August 11, 2020

Last Updated

October 21, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations